Zevra Therapeutics, Inc. (ZVRA)

SEC filing

Zevra Therapeutics, Inc.

ZVRA · CIK 1434647

4 · Oct 13, 2026 · Director, President and CEO McFarlane Neil F. sold 20K shares at $11.25/share ($224.9K); exercised options for 100K shares

Director, President and CEO McFarlane Neil F. sold 20K shares at $11.25/share ($224.9K); exercised options for 100K shares

FORM 4

xslF345X06/wk-form4_1791923065.xmlSEC.gov

Graphics and non-inline formats (not embedded below).